David P Bonita
CIK 1572451 · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TCDA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
601 LEXINGTON AVENUE, 54TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Director | 753,441 | $4.05 | $3.05M | $2.50M | 3 | 2026-06-18 |
| PRLD | Director | 1,126,126 | $3.70 | $4.17M | $41.00M | 10 | 2026-06-10 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 3,177,041 | $2.65 | $8.42M | $11.29M | 11 | 2024-06-20 |
| Third Harmonic Bio, Inc. (THRD) Delisted | Director | 5,779,071 | $5.38 | $31.09M | $5.10M | 5 | 2024-06-10 |
| ImageneBio, Inc. (IKNA) Delisted | Director | 13,107 | $17.16 | $224.9K | $12.42M | 9 | 2024-06-10 |
| Acutus Medical, Inc. (AFIB) Delisted | Director | 1,698,183 | $0.09 | $152.8K | $22.47M | 6 | 2023-06-15 |
| Tricida, Inc. (TCDA) Delisted | Director | 9,274,110 | $0.11 | $1.00M | -$47.11M | 9 | 2022-11-25 |
| Enliven Therapeutics, Inc. (IMRA) Delisted | Director | 1,049,767 | $14.59 | $15.32M | $35.00M | 5 | 2022-06-03 |
| SIBN | Director | 785,368 | $21.31 | $16.74M | $3.00M | 1 | 2018-10-19 |
| ViewRay, Inc. (VRAY) Delisted | Director | 115,613 | $0.03 | $2.9K | $4.35M | 4 | 2018-04-25 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 941,000 | — | — | -$69.20M | 9 | 2017-12-12 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Director | 13,947 | $0.54 | $7.5K | $5.66M | 2 | 2013-05-24 |
Recent Filings · Page 4 of 8
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-23 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-17 | Tricida, Inc. (TCDA) Delisted | Grant (A) | +666,667 | $4.00M | EDGAR |
| 2021-09-08 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −8,084 | -$274.8K | EDGAR |
| 2021-09-02 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −37,864 | -$1.29M | EDGAR |
| 2021-08-30 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −18,073 | -$615.7K | EDGAR |
| 2021-08-25 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −18,215 | -$622.4K | EDGAR |
| 2021-08-25 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −20,328 | -$693.2K | EDGAR |
| 2021-08-19 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −20,328 | -$693.2K | EDGAR |
| 2021-07-23 | Enliven Therapeutics, Inc. (IMRA) Delisted | Buy (P) | +1,666,666 | $10.00M | EDGAR |
| 2021-07-21 | Acutus Medical, Inc. (AFIB) Delisted | Buy (P) | +1,071,428 | $15.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.